Tokyo Tape
Sign in
← Miahelsa Holdings

Quarterly report · Q3

7129.TEDINET S100SRQ0
Period2023-04-01 → 2023-12-31
Filed2024-02-08
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 35
MetricValuePeriodScopeSource row
Revenue¥16.9bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥22.2bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥16.5bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥278m2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥39m2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥275m2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥169m2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥12m2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥204m2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax−¥59m2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥118m2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥210m2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥59m2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥118m2023-04-01 → 2023-12-31Cons.Profit loss
Net income−¥59m2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥14.2bnat 2023-12-31Cons.Assets
Total assets¥14.1bnat 2023-03-31Cons.Assets
Total assets¥14.0bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥10.8bnat 2023-12-31Cons.Liabilities
Total liabilities¥10.8bnat 2023-03-31Cons.Liabilities
Net assets / equity¥3.4bnat 2023-12-31Cons.Net assets
Net assets / equity¥3.3bnat 2023-03-31Cons.Net assets
Net assets / equity¥3.1bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥1.8bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥1.3bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥47.152023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥59.822023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥84.222022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-23.692022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-5.862022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥46.872023-04-01 → 2023-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥83.842022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
Equity ratio23.9%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio23.6%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio21.9%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-12-31¥715m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-12-31¥682m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-12-31¥33m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-12-31¥21m
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥33m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥33m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥569m
jpcrp040300-q3r_E36714-000Medicinereportable segmentrevenue2023-04-01 → 2023-12-31¥6.9bn
jpcrp040300-q3r_E36714-000Medicinereportable segmentrevenue external2023-04-01 → 2023-12-31¥6.9bn
jpcrp040300-q3r_E36714-000Medicinereportable segmentsegment profit2023-04-01 → 2023-12-31¥391m
jpcrp040300-q3r_E36714-000Nursing Care Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥2.5bn
jpcrp040300-q3r_E36714-000Nursing Care Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥2.5bn
jpcrp040300-q3r_E36714-000Nursing Care Businessreportable segmentsegment profit2023-04-01 → 2023-12-31−¥82m
jpcrp040300-q3r_E36714-000Nurturing Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥6.8bn
jpcrp040300-q3r_E36714-000Nurturing Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥6.8bn
jpcrp040300-q3r_E36714-000Nurturing Businessreportable segmentsegment profit2023-04-01 → 2023-12-31¥516m
—segment totalrevenue2023-04-01 → 2023-12-31¥16.2bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥16.2bn
—segment totalsegment profit2023-04-01 → 2023-12-31¥826m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥16.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥16.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-12-31¥33m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥847m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-12-31¥708m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-12-31¥688m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-12-31¥21m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31¥29m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥21m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥21m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥581m
jpcrp040300-q3r_E36714-000Medicinereportable segmentrevenue2022-04-01 → 2022-12-31¥6.7bn
jpcrp040300-q3r_E36714-000Medicinereportable segmentrevenue external2022-04-01 → 2022-12-31¥6.7bn
jpcrp040300-q3r_E36714-000Medicinereportable segmentsegment profit2022-04-01 → 2022-12-31¥380m
jpcrp040300-q3r_E36714-000Nursing Care Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥2.6bn
jpcrp040300-q3r_E36714-000Nursing Care Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥2.6bn
jpcrp040300-q3r_E36714-000Nursing Care Businessreportable segmentsegment profit2022-04-01 → 2022-12-31−¥108m
jpcrp040300-q3r_E36714-000Nurturing Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥6.5bn
jpcrp040300-q3r_E36714-000Nurturing Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥6.5bn
jpcrp040300-q3r_E36714-000Nurturing Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥319m
—segment totalrevenue2022-04-01 → 2022-12-31¥15.8bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥15.8bn
—segment totalsegment profit2022-04-01 → 2022-12-31¥591m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥16.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥16.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥21m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥619m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 406
ItemContextValueUnit
LiabilitiesPrior1YearInstant10798179000JPY
LiabilitiesCurrentQuarterInstant10844607000JPY
Capital stockPrior1YearInstant300620000JPY
Capital stockCurrentQuarterInstant311182000JPY
Capital surplusPrior1YearInstant517621000JPY
Capital surplusCurrentQuarterInstant528183000JPY
Retained earningsPrior1YearInstant2519493000JPY
Retained earningsCurrentQuarterInstant2562418000JPY
Treasury stockPrior1YearInstant-100000JPY
Treasury stockCurrentQuarterInstant-100000JPY
Shareholders equityPrior1YearInstant3337635000JPY
Shareholders equityCurrentQuarterInstant3401684000JPY
Valuation difference on available for sale securitiesPrior1YearInstant96000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant112000JPY
Valuation and translation adjustmentsPrior1YearInstant96000JPY
Valuation and translation adjustmentsCurrentQuarterInstant112000JPY
Subscription rights to sharesPrior1YearInstant－JPY
Subscription rights to sharesCurrentQuarterInstant1456000JPY
Net assetsPrior1YearInstant3337732000JPY
Net assetsCurrentQuarterInstant3403252000JPY
Liabilities and net assetsPrior1YearInstant14135911000JPY
Liabilities and net assetsCurrentQuarterInstant14247860000JPY
Net salesPrior1YTDDuration16533214000JPY
Net salesCurrentYTDDuration16886834000JPY
Cost of salesPrior1YTDDuration15135997000JPY
Cost of salesCurrentYTDDuration15294501000JPY
Gross profitPrior1YTDDuration1397217000JPY
Gross profitCurrentYTDDuration1592332000JPY
Selling general and administrative expensesPrior1YTDDuration1358303000JPY
Selling general and administrative expensesCurrentYTDDuration1314742000JPY
Operating incomePrior1YTDDuration38914000JPY
Operating incomeCurrentYTDDuration277590000JPY
Interest income noiPrior1YTDDuration74000JPY
Interest income noiCurrentYTDDuration55000JPY
Dividends income noiPrior1YTDDuration126000JPY
Dividends income noiCurrentYTDDuration274000JPY
Lease revenue noiPrior1YTDDuration50636000JPY
Lease revenue noiCurrentYTDDuration49977000JPY
Subsidy income noiPrior1YTDDuration5278000JPY
Subsidy income noiCurrentYTDDuration1857000JPY
Other noiPrior1YTDDuration12487000JPY
Other noiCurrentYTDDuration21909000JPY
Non operating incomePrior1YTDDuration68602000JPY
Non operating incomeCurrentYTDDuration74075000JPY
Interest expenses noePrior1YTDDuration26042000JPY
Interest expenses noeCurrentYTDDuration23303000JPY
Interest on bonds noePrior1YTDDuration325000JPY
Interest on bonds noeCurrentYTDDuration165000JPY
Rent cost noePrior1YTDDuration46652000JPY
Rent cost noeCurrentYTDDuration47404000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass